Telcyta: Started Phase III

TELK began the open-label, Doxil-controlled, U.S. Phase III ASSIST-3

Read the full 97 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE